Articles published by Veracyte

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

June 01, 2026

Tickers VCYT

OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer

May 21, 2026

From Veracyte

Via Business Wire

Tickers VCYT

Veracyte to Highlight Extensive Decipher® Data at 2026 ASCO GU Symposium

February 24, 2026

From Veracyte

Via Business Wire

Tickers VCYT

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium

February 11, 2025

From Veracyte

Via Business Wire

Tickers VCYT

Veracyte Announces that Data for Its Genomic and Immuno-Oncology Offerings Will Be Highlighted at the 2022 ASCO Annual Meeting

May 12, 2022

From Veracyte

Via Business Wire

Tickers VCYT

Veracyte Completes Acquisition of HalioDx

August 03, 2021

From Veracyte

Via Business Wire

Tickers VCYT

Veracyte to Present at Upcoming Investor Conferences

May 26, 2021

From Veracyte

Via Business Wire

Tickers VCYT

Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis

May 14, 2021

From Veracyte

Via Business Wire

Tickers VCYT

Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference

April 19, 2021

From Veracyte

Via Business Wire

Tickers VCYT

Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test

April 14, 2021

From Veracyte

Via Business Wire

Tickers VCYT

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.